OraSure Technologies, Inc.
OSUR Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow OSUR
OraSure Technologies, Inc. (OSUR) Beneish M-score
OraSure Technologies, Inc.'s Beneish M-score for fiscal 2025 is −2.73; values above −1.78 are the model's flag for possible earnings manipulation — a statistical screen, not a finding.
Beneish M-score, annual
Embed this chart
Annual newest first
| Period | Beneish M-score | Change (points) |
|---|---|---|
| FY2025 | −2.73 | 0.04 |
| FY2024 | −2.76 | 0.93 |
| FY2023 | −3.69 | (2.10) |
| FY2022 | −1.59 | 0.69 |
| FY2021 | −2.28 | 0.37 |
| FY2020 | −2.65 | (0.40) |
| FY2019 | −2.26 | 0.51 |
| FY2018 | −2.77 | (1.30) |
| FY2017 | −1.47 | 1.01 |
| FY2016 | −2.48 | 0.07 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Days’ sales in receivables index | 1.51 | — | 1.39 | |
| Gross margin index | 1.02 | — | 0.54 | |
| Asset quality index | 1.20 | — | 0.48 | |
| Sales growth index | 0.62 | — | 0.55 | |
| Depreciation index | 0.94 | — | 0.11 | |
| SG&A index | 1.54 | — | −0.27 | |
| Total accruals to total assets | (0.05) | — | −0.23 | |
| Leverage index | 1.41 | — | −0.46 | |
| Beneish M-score | Low — no pattern the model associates with manipulation | −2.73 | ||
How the Beneish M-score works
M = −4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI (Beneish, 1999): eight changes in the accounts from one fiscal year to the next, which the model weighs for the pattern seen in companies that later restated their earnings. Higher is worse.
| below −2.22 | Low — no pattern the model associates with manipulation |
|---|---|
| −2.22 to −1.78 | Elevated |
| above −1.78 | Flagged by the model |
−1.78 is the cut-off usually quoted from the paper, −2.22 a common conservative one. A statistical screen, not a finding of wrongdoing.
When asset quality, depreciation or SG&A cannot be worked out, that index is set to 1, as Beneish did, and the breakdown says so; with all three missing there is no score. Depreciation includes amortisation, and asset quality leaves out securities. Not worked out for banks, insurers and REITs.
Beneish M-score against peers
| Company | Beneish M-score |
|---|---|
| SMTI Sanara MedTech Inc. compare | −3.2× |
| EMBC Embecta Corp. compare | −3.1× |
| ANGO AngioDynamics, Inc. compare | −3.1× |
| KRMD KORU Medical Systems, Inc. compare | −2.9× |
| OSUR OraSure Technologies, Inc. | −2.7× |
| UTMD Utah Medical Products, Inc. compare | −2.7× |
| ZJYL Jin Medical International Ltd. compare | −2.5× |
| PDEX Pro-Dex, Inc. compare | −1.1× |
| NNNN Anbio Biotechnology compare | 2.0× |
What Beneish M-score is
The Beneish M-Score combines eight year-on-year changes in the accounts into a statistical screen for patterns seen in companies that overstated earnings.
−4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI